This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
e.l.f. Beauty (ELF) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
e.l.f. Beauty (ELF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is e.l.f. Beauty (ELF) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in e.l.f. Beauty (ELF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
E.l.f. Beauty (ELF) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
E.l.f. Beauty (ELF) concluded the recent trading session at $167.18, signifying a -1.75% move from its prior day's close.
e.l.f. Beauty (ELF) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching e.l.f. Beauty (ELF) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
E.l.f. Beauty (ELF) Stock Moves -0.76%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, e.l.f. Beauty (ELF) stood at $162.53, denoting a -0.76% change from the preceding trading day.
International Flavors (IFF) Sells Cosmetics Ingredients Business
by Zacks Equity Research
International Flavors' (IFF) sale of the Cosmetics Ingredients business aligns with its strategy to streamline its portfolio.
Take the Zacks Approach to Beat the Market: NVIDIA, Dell, Modine in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Colgate (CL) Benefits From Strong Pricing & Other Efforts
by Zacks Equity Research
Colgate (CL) has been on the growth track, driven by robust pricing actions, solid business momentum and accelerated revenue growth management plans.
Brokers Suggest Investing in e.l.f. Beauty (ELF): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Beat the Market the Zacks Way: Micron Technology, American Eagle Outfitters, Cencora in Focus
by Santanu Roy
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOG
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPSM
Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SLYG
International Flavors (IFF) Inks Deal to Sell Pharma Solutions
by Zacks Equity Research
International Flavors (IFF) agrees to sell its Pharma Solutions business, thus marking another step in its portfolio optimization strategy.
Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWO
Wall Street Bulls Look Optimistic About e.l.f. Beauty (ELF): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
COTY Benefits From Solid Beauty Trends and Partnerships
by Zacks Equity Research
Coty (COTY) is well-positioned to capitalize on favorable beauty trends. The company is making several strategic partnerships to enhance its brand portfolio.
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IWM
Should Vanguard S&P Small-Cap 600 ETF (VIOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOO
Wall Street Analysts Think e.l.f. Beauty (ELF) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for e.l.f. Beauty (ELF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
International Flavors (IFF) Q4 Earnings Lag Estimates, Dip Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q4 top line reflects softness in the Pharma and Nourish segments, offset by growth in the Scent, and Health & Biosciences segments.
Beat the Market the Zacks Way: Amazon, NVIDIA, SCREEN Holdings in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Helen of Troy (HELE) Benefits From Brand Strength & Project Pegasus
by Zacks Equity Research
Helen of Troy (HELE) is on track with Project Pegasus, which aims to expand operating margins via improved efficiency and lower costs.
TreeHouse Foods (THS) Q4 Earnings Beat, Sales Decline Y/Y
by Zacks Equity Research
TreeHouse Foods' (THS) fourth-quarter fiscal 2023 results reflect soft sales and earnings due to supply-chain hurdles at one of the broth facilities.
Service Corp (SCI) Hikes Dividend: What Else Should You Know?
by Zacks Equity Research
Service Corp (SCI) announces a dividend increase, showcasing its commitment to delivering value to its shareholders.